HHS

HHS Modifies Privacy Act System of Records

The Department of Health and Human Services (HHS) is modifying a Privacy Act system of records, System No. 09-90-0052, to include reporting on substance use disorder patient records. The comment period for these modifications ends on March 19, 2026.

HHS Drug Testing Panel Guidelines

The Department of Health and Human Services (HHS) has issued updated guidelines for authorized drug testing panels used in federal workplace drug testing programs. The current drug testing panels for urine and oral fluid, along with the required nomenclature for laboratory and Medical Review Officer Reports, remain in effect as of July 7, 2025, with minor edits to footnotes for clarity.

HHS Proposes Rescinding LGBTQI+ Children Placement Rule

The Administration for Children and Families (ACF) proposes to remove a final rule concerning designated placement requirements for LGBTQI+ children in foster care. This action follows a court decision vacating the rule, which the court found exceeded HHS's statutory authority. The public comment period for this proposed rescission ends April 6, 2026.

HHS Opioid Use Disorder Medications Correction

The Department of Health and Human Services (HHS) is issuing a correcting amendment to the final rule on Medications for the Treatment of Opioid Use Disorder. This document corrects outdated references within the regulation, with an effective date of February 23, 2026.

HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs

The Department of Health and Human Services (HHS) has published updated guidelines for federal workplace drug testing programs. The rule confirms that current authorized drug testing panels and required report nomenclature remain in effect.

HHS Benefit Parameters for 2027 and Basic Health Program Correction

The Department of Health and Human Services (HHS) has issued a proposed rule detailing benefit and payment parameters for the 2027 benefit year. This notice also includes a correction to the Basic Health Program. The rule outlines key parameters affecting health insurance marketplaces and programs.

HHS Proposes Rescinding LGBTQI+ Child Placement Rule

The Department of Health and Human Services (HHS) has proposed rescinding the Designated Placement Requirements under Titles IV-E and IV-B for LGBTQI+ children. This proposed rule seeks public comment on the removal of these requirements.

Kemin Industries Food Additive Petition for Animal Use

The Food and Drug Administration (FDA) is seeking public comment on a food additive petition filed by Kemin Industries, Inc. for animal use. The comment period for this proposed rule closes on April 3, 2026.

FDA Final Rule: Standardized NDC Format and Barcode Requirements

The Food and Drug Administration (FDA) has issued a final rule standardizing the National Drug Code (NDC) format and revising drug label barcode requirements. This rule aims to enhance drug tracking and safety. The effective date for this rule is March 7, 2033.

Opioid Use Disorder Medication Treatment Correction

The Department of Health and Human Services has issued a correction to its rule on Medications for the Treatment of Opioid Use Disorder. This correction clarifies specific provisions within the existing regulation, ensuring accurate implementation and adherence.